JP2018535999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535999A5 JP2018535999A5 JP2018528638A JP2018528638A JP2018535999A5 JP 2018535999 A5 JP2018535999 A5 JP 2018535999A5 JP 2018528638 A JP2018528638 A JP 2018528638A JP 2018528638 A JP2018528638 A JP 2018528638A JP 2018535999 A5 JP2018535999 A5 JP 2018535999A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydroxy
- dihydropyrimidin
- substituted
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 62
- -1 substituted Chemical class 0.000 claims 44
- 125000000623 heterocyclic group Chemical group 0.000 claims 37
- 229910052731 fluorine Inorganic materials 0.000 claims 32
- 229910052801 chlorine Inorganic materials 0.000 claims 31
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 22
- 229910052794 bromium Inorganic materials 0.000 claims 19
- 229910052799 carbon Inorganic materials 0.000 claims 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 229910052760 oxygen Inorganic materials 0.000 claims 13
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 12
- 229910004013 NO 2 Inorganic materials 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 11
- 125000004452 carbocyclyl group Chemical group 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 10
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 6
- 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 125000006706 (C3-C6) carbocyclyl group Chemical group 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 3
- 206010019280 Heart failures Diseases 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 claims 2
- HGJWTRQTKHPHAK-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-6-hydroxy-2-(3-methylbutyl)-5-[[4-(2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound COC1=CC=CC(OC)=C1N1C(CCC(C)C)=NC(O)=C(CC2=CC=C(C=C2)N2C=CC=CC2=O)C1=O HGJWTRQTKHPHAK-UHFFFAOYSA-N 0.000 claims 2
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 2
- ZELONHPQJRCHNY-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)F)=O)C=1SC=C(N=1)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)F)=O)C=1SC=C(N=1)C ZELONHPQJRCHNY-UHFFFAOYSA-N 0.000 claims 2
- VVQBNJDFIRRQCT-VWLOTQADSA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1CC1)O)[C@@H](CC)C=1C=C(C#N)C=CC=1 Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1CC1)O)[C@@H](CC)C=1C=C(C#N)C=CC=1 VVQBNJDFIRRQCT-VWLOTQADSA-N 0.000 claims 2
- ZHYCOWKZDNDIMS-SANMLTNESA-N CCOCC1=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C=NC=C2)=C(O)N1[C@@H](COC)C1=CC(F)=CC(F)=C1 Chemical compound CCOCC1=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C=NC=C2)=C(O)N1[C@@H](COC)C1=CC(F)=CC(F)=C1 ZHYCOWKZDNDIMS-SANMLTNESA-N 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- AHHWJWVMYCUFCN-MHZLTWQESA-N FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)=O)C1=NN(C=C1)CC Chemical compound FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)=O)C1=NN(C=C1)CC AHHWJWVMYCUFCN-MHZLTWQESA-N 0.000 claims 2
- QGNKMEDPCXKSAA-NDEPHWFRSA-N FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)=O)C1=NN(C=C1)CC Chemical compound FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)=O)C1=NN(C=C1)CC QGNKMEDPCXKSAA-NDEPHWFRSA-N 0.000 claims 2
- 206010049694 Left Ventricular Dysfunction Diseases 0.000 claims 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 2
- 230000002107 myocardial effect Effects 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 238000007634 remodeling Methods 0.000 claims 2
- DEXJWKSVVYKYFQ-UHFFFAOYSA-N 2-(2-cyclopropylethyl)-3-(2,6-dimethoxyphenyl)-5-[[4-(5-fluoro-2-oxopyridin-1-yl)phenyl]methyl]-6-hydroxypyrimidin-4-one Chemical compound COC1=CC=CC(OC)=C1N1C(CCC2CC2)=NC(O)=C(CC2=CC=C(C=C2)N2C=C(F)C=CC2=O)C1=O DEXJWKSVVYKYFQ-UHFFFAOYSA-N 0.000 claims 1
- KYFFPIYRYJBDFZ-UHFFFAOYSA-N 2-(2-cyclopropylethyl)-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound COC1=CC=CC(OC)=C1N1C(CCC2CC2)=NC(O)=C(CC2=CC=C(C=C2)N2C=CC=CC2=O)C1=O KYFFPIYRYJBDFZ-UHFFFAOYSA-N 0.000 claims 1
- BSPYCDJNRMZTTD-UHFFFAOYSA-N 2-(2-cyclopropylethyl)-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(5-methyl-2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C1(CC1)CCC1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1C(C=CC(=C1)C)=O)O BSPYCDJNRMZTTD-UHFFFAOYSA-N 0.000 claims 1
- HGIRVSHGAIOACS-UHFFFAOYSA-N 2-(cyclobutyloxymethyl)-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C1(CCC1)OCC1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1C(C=CC=C1)=O)O HGIRVSHGAIOACS-UHFFFAOYSA-N 0.000 claims 1
- IIUNGCGMTIHKHK-UHFFFAOYSA-N 2-(cyclopropyloxymethyl)-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C1(CC1)OCC1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1C(C=CC=C1)=O)O IIUNGCGMTIHKHK-UHFFFAOYSA-N 0.000 claims 1
- JDMWHPFESDHWQY-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-5-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]-6-hydroxypyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=C(C=C(C=C1)C1=NOC=N1)F)O JDMWHPFESDHWQY-UHFFFAOYSA-N 0.000 claims 1
- TUOQQEKBKGIDFY-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-5-[[3-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]-6-hydroxypyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC(=C(C=C1)C1=NOC=N1)F)O TUOQQEKBKGIDFY-UHFFFAOYSA-N 0.000 claims 1
- GMOJSPSBHRDCDI-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-5-[[4-(5-fluoro-2-oxopyridin-1-yl)phenyl]methyl]-6-hydroxypyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1C(C=CC(=C1)F)=O)O GMOJSPSBHRDCDI-UHFFFAOYSA-N 0.000 claims 1
- JBARFQRXBFNRLN-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[(4-methoxyphenyl)methyl]pyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CC=C(OC)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC JBARFQRXBFNRLN-UHFFFAOYSA-N 0.000 claims 1
- QPLCKLBAVJVRQD-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[(4-methylsulfonylphenyl)methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)S(=O)(=O)C)O QPLCKLBAVJVRQD-UHFFFAOYSA-N 0.000 claims 1
- AOIYMGAIOSGHMP-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[(4-morpholin-4-ylphenyl)methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1CCOCC1)O AOIYMGAIOSGHMP-UHFFFAOYSA-N 0.000 claims 1
- HDDLUTRVJPJILA-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[(4-phenylphenyl)methyl]pyrimidin-4-one Chemical compound C1(=CC=C(C=C1)CC=1C(N(C(=NC=1O)CCCC)C1=C(C=CC=C1OC)OC)=O)C1=CC=CC=C1 HDDLUTRVJPJILA-UHFFFAOYSA-N 0.000 claims 1
- XNWOGYXBCXSGFL-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[(4-pyrazol-1-ylphenyl)methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1N=CC=C1)O XNWOGYXBCXSGFL-UHFFFAOYSA-N 0.000 claims 1
- IFGNEVPLPJPXDF-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[(5-methyl-1,2-oxazol-3-yl)methyl]pyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=NOC(C)=C2)C(=O)N1C1=C(OC)C=CC=C1OC IFGNEVPLPJPXDF-UHFFFAOYSA-N 0.000 claims 1
- RUKHJDQBAQIBIN-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[1-(4-methylphenyl)pyrazol-4-yl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC=1C=NN(C=1)C1=CC=C(C=C1)C)O RUKHJDQBAQIBIN-UHFFFAOYSA-N 0.000 claims 1
- GRZBICINDMXGMW-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[2-(4-methylphenyl)-1,3-thiazol-4-yl]methyl]pyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CSC(=N2)C2=CC=C(C)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC GRZBICINDMXGMW-UHFFFAOYSA-N 0.000 claims 1
- BXHRXWNZIIGGGE-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]pyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=NC(=NO2)C2=CC=C(C=C2)C(F)(F)F)C(=O)N1C1=C(OC)C=CC=C1OC BXHRXWNZIIGGGE-UHFFFAOYSA-N 0.000 claims 1
- VRZFZEBAYSGHGV-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)C1=NOC=N1)O VRZFZEBAYSGHGV-UHFFFAOYSA-N 0.000 claims 1
- XDXYIEJZZFXBTQ-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(2-methoxypyridin-3-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)OC)O XDXYIEJZZFXBTQ-UHFFFAOYSA-N 0.000 claims 1
- XADIDGSFRZTKQS-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(2-oxopiperidin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1C(CCCC1)=O)O XADIDGSFRZTKQS-UHFFFAOYSA-N 0.000 claims 1
- SESDBEINZBEEAO-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1C(C=CC=C1)=O)O SESDBEINZBEEAO-UHFFFAOYSA-N 0.000 claims 1
- IUPFRCINSYZIGR-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]methyl]pyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CC=C(C=C2)C2=NC(C)=NO2)C(=O)N1C1=C(OC)C=CC=C1OC IUPFRCINSYZIGR-UHFFFAOYSA-N 0.000 claims 1
- XKLKBHFLDVDRAJ-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(4-methyl-2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CC=C(C=C2)N2C=CC(C)=CC2=O)C(=O)N1C1=C(OC)C=CC=C1OC XKLKBHFLDVDRAJ-UHFFFAOYSA-N 0.000 claims 1
- MBHXUKOKNNDSDR-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(5-methyl-2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)N1C(C=CC(=C1)C)=O)O MBHXUKOKNNDSDR-UHFFFAOYSA-N 0.000 claims 1
- ALLWKQWMFICPCV-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(6-methylpyridin-3-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)C=1C=NC(=CC=1)C)O ALLWKQWMFICPCV-UHFFFAOYSA-N 0.000 claims 1
- LCFDGEBETWIKBT-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(pyrazol-1-ylmethyl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)CN1N=CC=C1)O LCFDGEBETWIKBT-UHFFFAOYSA-N 0.000 claims 1
- ITXZIJLUVAQUOM-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(thiadiazol-4-yl)phenyl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)C=1N=NSC=1)O ITXZIJLUVAQUOM-UHFFFAOYSA-N 0.000 claims 1
- JHPFVOOHRVMABK-UHFFFAOYSA-N 2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[6-(4-methoxyphenyl)pyridin-3-yl]methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC=1C=NC(=CC=1)C1=CC=C(C=C1)OC)O JHPFVOOHRVMABK-UHFFFAOYSA-N 0.000 claims 1
- JWXROJLBOHUAMT-UHFFFAOYSA-N 2-butyl-5-[[1-(4-chlorophenyl)pyrazol-3-yl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=NN(C=C2)C2=CC=C(Cl)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC JWXROJLBOHUAMT-UHFFFAOYSA-N 0.000 claims 1
- BZGOXDLNTXGOBV-UHFFFAOYSA-N 2-butyl-5-[[2-(4-chlorophenyl)-1,3-oxazol-4-yl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC=1N=C(OC=1)C1=CC=C(C=C1)Cl)O BZGOXDLNTXGOBV-UHFFFAOYSA-N 0.000 claims 1
- UNXNIAOXAOTUJE-UHFFFAOYSA-N 2-butyl-5-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CSC(=N2)C2=CC=C(Cl)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC UNXNIAOXAOTUJE-UHFFFAOYSA-N 0.000 claims 1
- DHPFHDOTELNZHZ-UHFFFAOYSA-N 2-butyl-5-[[2-(4-chlorophenyl)-1,3-thiazol-5-yl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CN=C(S2)C2=CC=C(Cl)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC DHPFHDOTELNZHZ-UHFFFAOYSA-N 0.000 claims 1
- JLGSETLJYWWOLR-UHFFFAOYSA-N 2-butyl-5-[[4-(4-chloro-2-oxopyridin-1-yl)phenyl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CC=C(C=C2)N2C=CC(Cl)=CC2=O)C(=O)N1C1=C(OC)C=CC=C1OC JLGSETLJYWWOLR-UHFFFAOYSA-N 0.000 claims 1
- NXRUBGAYGHJUJW-UHFFFAOYSA-N 2-butyl-5-[[4-(5-chloro-2-oxopyridin-1-yl)phenyl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CC=C(C=C2)N2C=C(Cl)C=CC2=O)C(=O)N1C1=C(OC)C=CC=C1OC NXRUBGAYGHJUJW-UHFFFAOYSA-N 0.000 claims 1
- UIBYULIMAQITBQ-UHFFFAOYSA-N 2-butyl-5-[[4-(5-chloropyridin-2-yl)phenyl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC1=CC=C(C=C1)C1=NC=C(C=C1)Cl)O UIBYULIMAQITBQ-UHFFFAOYSA-N 0.000 claims 1
- JCIQKZHZHYVHDC-UHFFFAOYSA-N 2-butyl-5-[[6-(4-chlorophenyl)pyridin-3-yl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1OC)OC)=O)CC=1C=NC(=CC=1)C1=CC=C(C=C1)Cl)O JCIQKZHZHYVHDC-UHFFFAOYSA-N 0.000 claims 1
- MCVTUWWMRVPWNU-UHFFFAOYSA-N 2-butyl-6-hydroxy-3-(2-methoxyphenyl)-5-[(4-methoxyphenyl)methyl]pyrimidin-4-one Chemical compound C(CCC)C1=NC(=C(C(N1C1=C(C=CC=C1)OC)=O)CC1=CC=C(C=C1)OC)O MCVTUWWMRVPWNU-UHFFFAOYSA-N 0.000 claims 1
- QQOWSFYAETWFMT-UHFFFAOYSA-N 2-cyclopentyl-3-(2,6-dimethoxyphenyl)-5-[[4-(5-fluoro-2-oxopyridin-1-yl)phenyl]methyl]-6-hydroxypyrimidin-4-one Chemical compound COc1cccc(OC)c1-n1c(nc(O)c(Cc2ccc(cc2)-n2cc(F)ccc2=O)c1=O)C1CCCC1 QQOWSFYAETWFMT-UHFFFAOYSA-N 0.000 claims 1
- MOLWRKPVZLLZRT-UHFFFAOYSA-N 2-cyclopentyl-3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound COc1cccc(OC)c1-n1c(nc(O)c(Cc2ccc(cc2)-n2ccccc2=O)c1=O)C1CCCC1 MOLWRKPVZLLZRT-UHFFFAOYSA-N 0.000 claims 1
- OQFOPKWPGZURTK-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-2-(ethoxymethyl)-6-hydroxy-5-[[4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]pyrimidin-4-one Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NC(=C(C1=O)CC1=CC=C(C=C1)C1=NOC=N1)O)COCC OQFOPKWPGZURTK-UHFFFAOYSA-N 0.000 claims 1
- CMOKHSAYEMUZGD-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-5-[[4-(5-fluoro-2-oxopyridin-1-yl)phenyl]methyl]-2-(4-fluorophenyl)-6-hydroxypyrimidin-4-one Chemical compound COC1=CC=CC(OC)=C1N1C(=O)C(CC2=CC=C(C=C2)N2C=C(F)C=CC2=O)=C(O)N=C1C1=CC=C(F)C=C1 CMOKHSAYEMUZGD-UHFFFAOYSA-N 0.000 claims 1
- RZURKLQGVMXDQN-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-5-[[4-(5-fluoro-2-oxopyridin-1-yl)phenyl]methyl]-6-hydroxy-2-(3-methylbutyl)pyrimidin-4-one Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NC(=C(C1=O)CC1=CC=C(C=C1)N1C(C=CC(=C1)F)=O)O)CCC(C)C RZURKLQGVMXDQN-UHFFFAOYSA-N 0.000 claims 1
- OWIZGITVPNTPGS-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-5-[[4-(5-fluoro-2-oxopyridin-1-yl)phenyl]methyl]-6-hydroxy-2-(propan-2-yloxymethyl)pyrimidin-4-one Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NC(=C(C1=O)CC1=CC=C(C=C1)N1C(C=CC(=C1)F)=O)O)COC(C)C OWIZGITVPNTPGS-UHFFFAOYSA-N 0.000 claims 1
- OBXNJFPWRGBUOT-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-6-hydroxy-2-(3-methylbutyl)-5-[[4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]pyrimidin-4-one Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NC(=C(C1=O)CC1=CC=C(C=C1)C1=NOC=N1)O)CCC(C)C OBXNJFPWRGBUOT-UHFFFAOYSA-N 0.000 claims 1
- JVOCFGLDTNBOJD-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-6-hydroxy-2-(3-methylbutyl)-5-[[4-(5-methyl-2-oxopyridin-1-yl)phenyl]methyl]pyrimidin-4-one Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NC(=C(C1=O)CC1=CC=C(C=C1)N1C(C=CC(=C1)C)=O)O)CCC(C)C JVOCFGLDTNBOJD-UHFFFAOYSA-N 0.000 claims 1
- WSWLJWVYUJQTNY-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-6-hydroxy-2-(3-methylbutyl)-5-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]pyrimidin-4-one Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NC(=C(C1=O)CC=1OC(=NN=1)C1=CC=C(C=C1)C)O)CCC(C)C WSWLJWVYUJQTNY-UHFFFAOYSA-N 0.000 claims 1
- AXEODLPYTXWXIH-UHFFFAOYSA-N 3-(2,6-dimethoxyphenyl)-6-hydroxy-5-[[4-(5-methyl-2-oxopyridin-1-yl)phenyl]methyl]-2-(propan-2-yloxymethyl)pyrimidin-4-one Chemical compound COC1=CC=CC(OC)=C1N1C(COC(C)C)=NC(O)=C(CC2=CC=C(C=C2)N2C=C(C)C=CC2=O)C1=O AXEODLPYTXWXIH-UHFFFAOYSA-N 0.000 claims 1
- XAYXTDYVZGISEK-UHFFFAOYSA-N 4-[[2-butyl-1-(2,6-dimethoxyphenyl)-4-hydroxy-6-oxopyrimidin-5-yl]methyl]-N-ethylbenzamide Chemical compound C(CCC)C=1N(C(C(=C(N=1)O)CC1=CC=C(C(=O)NCC)C=C1)=O)C1=C(C=CC=C1OC)OC XAYXTDYVZGISEK-UHFFFAOYSA-N 0.000 claims 1
- XPXDVKPFIFSNHD-UHFFFAOYSA-N 5-[(1-benzylpyrazol-4-yl)methyl]-2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)CC=1C(N(C(=NC=1O)CCCC)C1=C(C=CC=C1OC)OC)=O XPXDVKPFIFSNHD-UHFFFAOYSA-N 0.000 claims 1
- JMBFDQQRFQOAGK-UHFFFAOYSA-N 5-[[1-(4-chlorophenyl)pyrazol-3-yl]methyl]-3-(2,6-dimethoxyphenyl)-2-(ethoxymethyl)-6-hydroxypyrimidin-4-one Chemical compound CCOCC1=NC(O)=C(CC2=NN(C=C2)C2=CC=C(Cl)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC JMBFDQQRFQOAGK-UHFFFAOYSA-N 0.000 claims 1
- XHANFLBLHDJXTE-UHFFFAOYSA-N 5-[[2-(4-chlorophenyl)-1,3-oxazol-4-yl]methyl]-3-(2,6-dimethoxyphenyl)-2-(ethoxymethyl)-6-hydroxypyrimidin-4-one Chemical compound CCOCC1=NC(O)=C(CC2=COC(=N2)C2=CC=C(Cl)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC XHANFLBLHDJXTE-UHFFFAOYSA-N 0.000 claims 1
- SCHHGODTDWWIPX-UHFFFAOYSA-N 5-[[2-(4-chlorophenyl)-1,3-oxazol-4-yl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxy-2-(3-methylbutyl)pyrimidin-4-one Chemical compound ClC1=CC=C(C=C1)C=1OC=C(N=1)CC=1C(N(C(=NC=1O)CCC(C)C)C1=C(C=CC=C1OC)OC)=O SCHHGODTDWWIPX-UHFFFAOYSA-N 0.000 claims 1
- BZEVEABNUWNGPQ-UHFFFAOYSA-N 5-[[4-(5-chloro-2-oxopyridin-1-yl)phenyl]methyl]-2-(2-cyclopropylethyl)-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound ClC=1C=CC(N(C=1)C1=CC=C(C=C1)CC=1C(N(C(=NC=1O)CCC1CC1)C1=C(C=CC=C1OC)OC)=O)=O BZEVEABNUWNGPQ-UHFFFAOYSA-N 0.000 claims 1
- ZTIZFGZYJKVLJN-UHFFFAOYSA-N 5-[[4-(5-chloro-2-oxopyridin-1-yl)phenyl]methyl]-3-(2,6-dimethoxyphenyl)-6-hydroxy-2-(propan-2-yloxymethyl)pyrimidin-4-one Chemical compound ClC=1C=CC(N(C=1)C1=CC=C(C=C1)CC=1C(N(C(=NC=1O)COC(C)C)C1=C(C=CC=C1OC)OC)=O)=O ZTIZFGZYJKVLJN-UHFFFAOYSA-N 0.000 claims 1
- HLVZANFVDITNTQ-UHFFFAOYSA-N 5-benzyl-2-butyl-3-(2,6-dimethoxyphenyl)-6-hydroxypyrimidin-4-one Chemical compound CCCCC1=NC(O)=C(CC2=CC=CC=C2)C(=O)N1C1=C(OC)C=CC=C1OC HLVZANFVDITNTQ-UHFFFAOYSA-N 0.000 claims 1
- XODBYYCUYOJELB-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=C(C=C(C=C1)C=1C(N(C=CC=1)C)=O)F)=O)C1=NN(C=C1)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=C(C=C(C=C1)C=1C(N(C=CC=1)C)=O)F)=O)C1=NN(C=C1)C XODBYYCUYOJELB-UHFFFAOYSA-N 0.000 claims 1
- NNOHFJBWBYLHMO-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C1=C(C(=NC=C1)F)C)F)=O)C=1SC=C(N=1)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C1=C(C(=NC=C1)F)C)F)=O)C=1SC=C(N=1)C NNOHFJBWBYLHMO-UHFFFAOYSA-N 0.000 claims 1
- MFQUDNRYLRPUKH-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C1=C(C=NC=C1)C)F)=O)C=1N=C(SC=1)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C1=C(C=NC=C1)C)F)=O)C=1N=C(SC=1)C MFQUDNRYLRPUKH-UHFFFAOYSA-N 0.000 claims 1
- SRMHZKNHJNKYDA-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)F)=O)C1=NN(C=C1)C(C)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)F)=O)C1=NN(C=C1)C(C)C SRMHZKNHJNKYDA-UHFFFAOYSA-N 0.000 claims 1
- FQZSWEWBEAHOSR-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)F)=O)C1=NN(C=C1)CC(C)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)F)=O)C1=NN(C=C1)CC(C)C FQZSWEWBEAHOSR-UHFFFAOYSA-N 0.000 claims 1
- KJUXKRRGEDCCEE-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=NC(=CC=1)F)C)F)=O)C=1N=C(SC=1)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=NC(=CC=1)F)C)F)=O)C=1N=C(SC=1)C KJUXKRRGEDCCEE-UHFFFAOYSA-N 0.000 claims 1
- WOSJRUAWGSVEIU-UHFFFAOYSA-N C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=NC(=CC=1)F)C)F)=O)C=1SC=C(N=1)C Chemical compound C(C)C1=C(C(=CC=C1)CC)N1C(=NC(C(=C1O)CC1=CC(=C(C=C1)C=1C(=NC(=CC=1)F)C)F)=O)C=1SC=C(N=1)C WOSJRUAWGSVEIU-UHFFFAOYSA-N 0.000 claims 1
- LOVTXJAIILZLGA-UHFFFAOYSA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)O)C1=C(C=CC=C1CC)CC Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)O)C1=C(C=CC=C1CC)CC LOVTXJAIILZLGA-UHFFFAOYSA-N 0.000 claims 1
- VWSHJDLYVNMYTO-SANMLTNESA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)O)[C@@H](CC)C1=CC(=CC=C1)F Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)O)[C@@H](CC)C1=CC(=CC=C1)F VWSHJDLYVNMYTO-SANMLTNESA-N 0.000 claims 1
- IPBFLTQHXXNWFU-MHZLTWQESA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)O)[C@@H](CC)C1=CC(=CC=C1)F Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)O)[C@@H](CC)C1=CC(=CC=C1)F IPBFLTQHXXNWFU-MHZLTWQESA-N 0.000 claims 1
- OGVXZBNIMZGCER-NDEPHWFRSA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)O)[C@@H](CC)C=1C=C(C#N)C=CC=1 Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)O)[C@@H](CC)C=1C=C(C#N)C=CC=1 OGVXZBNIMZGCER-NDEPHWFRSA-N 0.000 claims 1
- UXBMAECPRDGUDT-UHFFFAOYSA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1CC1)O)C1=C(C=CC=C1CC)CC Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C1CC1)O)C1=C(C=CC=C1CC)CC UXBMAECPRDGUDT-UHFFFAOYSA-N 0.000 claims 1
- MYOLFZWLUAPLIL-UHFFFAOYSA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)O)C1=C(C=CC=C1CC)CC Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)O)C1=C(C=CC=C1CC)CC MYOLFZWLUAPLIL-UHFFFAOYSA-N 0.000 claims 1
- SXYJYOOMDZLWBH-SANMLTNESA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)O)[C@@H](CC)C1=CC(=CC=C1)F Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)O)[C@@H](CC)C1=CC(=CC=C1)F SXYJYOOMDZLWBH-SANMLTNESA-N 0.000 claims 1
- DVPIPFDUYDSWSR-MHZLTWQESA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)O)[C@@H](CC)C1=CC(=CC=C1)F Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)O)[C@@H](CC)C1=CC(=CC=C1)F DVPIPFDUYDSWSR-MHZLTWQESA-N 0.000 claims 1
- IFXGEPNBHPYMCU-UHFFFAOYSA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C=NC(=CC=1)F)O)C1=C(C=CC=C1CC)CC Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C=NC(=CC=1)F)O)C1=C(C=CC=C1CC)CC IFXGEPNBHPYMCU-UHFFFAOYSA-N 0.000 claims 1
- NKHABRCYLMYTSH-SANMLTNESA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C=NC(=CC=1)F)O)[C@@H](CC)C=1C=C(C#N)C=CC=1 Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C=NC(=CC=1)F)O)[C@@H](CC)C=1C=C(C#N)C=CC=1 NKHABRCYLMYTSH-SANMLTNESA-N 0.000 claims 1
- GOXUPHRDASUXCD-MHZLTWQESA-N C(CCC)C=1N(C(=C(C(N=1)=O)CC=1C=C(C=CC=1)C=1C(=CC(=CC=1)F)C(=O)N)O)[C@@H](CC)C1=CC(=CC(=C1)F)F Chemical compound C(CCC)C=1N(C(=C(C(N=1)=O)CC=1C=C(C=CC=1)C=1C(=CC(=CC=1)F)C(=O)N)O)[C@@H](CC)C1=CC(=CC(=C1)F)F GOXUPHRDASUXCD-MHZLTWQESA-N 0.000 claims 1
- DDQFWWYOJQDLTF-UHFFFAOYSA-N C1(=CC=C(C=C1)CC=1C(N=C(N(C=1O)C1=C(C=CC=C1CC)CC)CCCC)=O)C1=CC=CC=C1 Chemical compound C1(=CC=C(C=C1)CC=1C(N=C(N(C=1O)C1=C(C=CC=C1CC)CC)CCCC)=O)C1=CC=CC=C1 DDQFWWYOJQDLTF-UHFFFAOYSA-N 0.000 claims 1
- MDTSCFAYJGCORZ-PMERELPUSA-N C1(CC1)CCC=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)O)[C@@H](C(C)C)C1=CC(=CC(=C1)F)F Chemical compound C1(CC1)CCC=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=CC(=CC=1)F)C(=O)N)O)[C@@H](C(C)C)C1=CC(=CC(=C1)F)F MDTSCFAYJGCORZ-PMERELPUSA-N 0.000 claims 1
- JHYVDDGHKAPIFQ-MHZLTWQESA-N C1(CC1)CCC=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)O)[C@@H](CC)C1=CC(=CC(=C1)F)F Chemical compound C1(CC1)CCC=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)O)[C@@H](CC)C1=CC(=CC(=C1)F)F JHYVDDGHKAPIFQ-MHZLTWQESA-N 0.000 claims 1
- AFGYLSBYCNCSAT-NDEPHWFRSA-N C1(CC1)CCC=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)O)[C@@H](CC)C1=CC(=CC(=C1)F)F Chemical compound C1(CC1)CCC=1N(C(=C(C(N=1)=O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)O)[C@@H](CC)C1=CC(=CC(=C1)F)F AFGYLSBYCNCSAT-NDEPHWFRSA-N 0.000 claims 1
- WFPPRZCZMVCDRH-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=C(F)C=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(C)C=C1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=C(F)C=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(C)C=C1 WFPPRZCZMVCDRH-UHFFFAOYSA-N 0.000 claims 1
- ROUVLWLHWGBBPQ-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=C(F)C=C(C=C2)C2=C(C=C(F)C=C2)C(N)=O)C(=O)N=C1C1=NN(C)C=C1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=C(F)C=C(C=C2)C2=C(C=C(F)C=C2)C(N)=O)C(=O)N=C1C1=NN(C)C=C1 ROUVLWLHWGBBPQ-UHFFFAOYSA-N 0.000 claims 1
- RLFJOPHXOCFJME-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=CSC(C)=N1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=CSC(C)=N1 RLFJOPHXOCFJME-UHFFFAOYSA-N 0.000 claims 1
- QYEGFHAWEUPKIP-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(C)C=C1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(C)C=C1 QYEGFHAWEUPKIP-UHFFFAOYSA-N 0.000 claims 1
- LCTDIVDXTFRDKH-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(C=C1)C(C)C Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(C=C1)C(C)C LCTDIVDXTFRDKH-UHFFFAOYSA-N 0.000 claims 1
- DIYOCISMHPFJQK-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(CC(C)C)C=C1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C(F)=NC=C2)C(=O)N=C1C1=NN(CC(C)C)C=C1 DIYOCISMHPFJQK-UHFFFAOYSA-N 0.000 claims 1
- AVDQSCYZQADCQF-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C=NC=C2)C(=O)N=C1C1=NN(C)C=C1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C)C=NC=C2)C(=O)N=C1C1=NN(C)C=C1 AVDQSCYZQADCQF-UHFFFAOYSA-N 0.000 claims 1
- OGNZBMDIHUEFPQ-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C=C(F)C=C2)C(N)=O)C(=O)N=C1C1=NN(C=C1)C1CC1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C=C(F)C=C2)C(N)=O)C(=O)N=C1C1=NN(C=C1)C1CC1 OGNZBMDIHUEFPQ-UHFFFAOYSA-N 0.000 claims 1
- ZJOJSPHNURUKAY-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=CC=C(F)N=C2C)C(=O)N=C1C1=NN(C)C=C1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=CC=C(F)N=C2C)C(=O)N=C1C1=NN(C)C=C1 ZJOJSPHNURUKAY-UHFFFAOYSA-N 0.000 claims 1
- JHNMCSUVMFEMGH-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=CC=CN(C)C2=O)C(=O)N=C1C1=NC(C)=CS1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=CC=CN(C)C2=O)C(=O)N=C1C1=NC(C)=CS1 JHNMCSUVMFEMGH-UHFFFAOYSA-N 0.000 claims 1
- YYFSEGCTQWPTPM-UHFFFAOYSA-N CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=CC=CN(C)C2=O)C(=O)N=C1C1=NN(CC(C)C)C=C1 Chemical compound CCC1=CC=CC(CC)=C1N1C(O)=C(CC2=CC(F)=C(C=C2)C2=CC=CN(C)C2=O)C(=O)N=C1C1=NN(CC(C)C)C=C1 YYFSEGCTQWPTPM-UHFFFAOYSA-N 0.000 claims 1
- BXNKHFFKVNWLLT-SANMLTNESA-N CCCCC1=NC(=O)C(CC2=CC(=CC=C2)C2=C(C)C(F)=NC=C2)=C(O)N1[C@@H](CC)C1=CC(F)=CC(F)=C1 Chemical compound CCCCC1=NC(=O)C(CC2=CC(=CC=C2)C2=C(C)C(F)=NC=C2)=C(O)N1[C@@H](CC)C1=CC(F)=CC(F)=C1 BXNKHFFKVNWLLT-SANMLTNESA-N 0.000 claims 1
- ZPYKHNXNKYZTLB-SANMLTNESA-N CCCCC1=NC(=O)C(CC2=CC(=CC=C2)C2=CC=C(F)N=C2C)=C(O)N1[C@@H](CC)C1=CC(F)=CC(F)=C1 Chemical compound CCCCC1=NC(=O)C(CC2=CC(=CC=C2)C2=CC=C(F)N=C2C)=C(O)N1[C@@H](CC)C1=CC(F)=CC(F)=C1 ZPYKHNXNKYZTLB-SANMLTNESA-N 0.000 claims 1
- IGZSLDFZGITFAH-MHZLTWQESA-N CCCCC1=NC(=O)C(CC2=CC(=CC=C2)C2=CC=CN=C2C)=C(O)N1[C@@H](CC)C1=CC(F)=CC(F)=C1 Chemical compound CCCCC1=NC(=O)C(CC2=CC(=CC=C2)C2=CC=CN=C2C)=C(O)N1[C@@H](CC)C1=CC(F)=CC(F)=C1 IGZSLDFZGITFAH-MHZLTWQESA-N 0.000 claims 1
- GFQFYKORMRFNGS-MHZLTWQESA-N CCCCC1=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C(F)=NC=C2)=C(O)N1[C@@H](CC)C1=CC=CC(=C1)C#N Chemical compound CCCCC1=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C(F)=NC=C2)=C(O)N1[C@@H](CC)C1=CC=CC(=C1)C#N GFQFYKORMRFNGS-MHZLTWQESA-N 0.000 claims 1
- WBYSUHKWZWMGGB-MHZLTWQESA-N CCCCC1=NC(=O)C(CC2=CC=C(C=C2)C2=CC=C(F)N=C2C)=C(O)N1[C@@H](CC)C1=CC=CC(=C1)C#N Chemical compound CCCCC1=NC(=O)C(CC2=CC=C(C=C2)C2=CC=C(F)N=C2C)=C(O)N1[C@@H](CC)C1=CC=CC(=C1)C#N WBYSUHKWZWMGGB-MHZLTWQESA-N 0.000 claims 1
- CCFWYHSADSDYHK-MHZLTWQESA-N CCCCc1nc(=O)c(Cc2cccc(c2)-c2ccncc2C)c(O)n1[C@@H](CC)c1cc(F)cc(F)c1 Chemical compound CCCCc1nc(=O)c(Cc2cccc(c2)-c2ccncc2C)c(O)n1[C@@H](CC)c1cc(F)cc(F)c1 CCFWYHSADSDYHK-MHZLTWQESA-N 0.000 claims 1
- XRDWYPWEUUAOEA-MHZLTWQESA-N CC[C@H](N1C(CCC2CC2)=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C(F)=NC=C2)=C1O)C1=CC(F)=CC(F)=C1 Chemical compound CC[C@H](N1C(CCC2CC2)=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C(F)=NC=C2)=C1O)C1=CC(F)=CC(F)=C1 XRDWYPWEUUAOEA-MHZLTWQESA-N 0.000 claims 1
- WMRBKAYTVJIWAM-NDEPHWFRSA-N CC[C@H](N1C(CCC2CC2)=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C=NC=C2)=C1O)C1=CC(F)=CC(F)=C1 Chemical compound CC[C@H](N1C(CCC2CC2)=NC(=O)C(CC2=CC=C(C=C2)C2=C(C)C=NC=C2)=C1O)C1=CC(F)=CC(F)=C1 WMRBKAYTVJIWAM-NDEPHWFRSA-N 0.000 claims 1
- FQQBETFSUFVKER-SANMLTNESA-N CC[C@H](N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C=C(F)C=C2)C(N)=O)C(=O)N=C1C1=NC(C)=CS1)C1=CC=CC=C1 Chemical compound CC[C@H](N1C(O)=C(CC2=CC(F)=C(C=C2)C2=C(C=C(F)C=C2)C(N)=O)C(=O)N=C1C1=NC(C)=CS1)C1=CC=CC=C1 FQQBETFSUFVKER-SANMLTNESA-N 0.000 claims 1
- KWXLPMWUIQBTFB-SANMLTNESA-N CC[C@H](N1C(O)=C(CC2=CC=C(C=C2)C2=CC=C(F)N=C2)C(=O)N=C1C1=NN(CC)C=C1)C1=CC(F)=CC(F)=C1 Chemical compound CC[C@H](N1C(O)=C(CC2=CC=C(C=C2)C2=CC=C(F)N=C2)C(=O)N=C1C1=NN(CC)C=C1)C1=CC(F)=CC(F)=C1 KWXLPMWUIQBTFB-SANMLTNESA-N 0.000 claims 1
- LYZSSOLTQLAWLL-NDEPHWFRSA-N CC[C@H](N1C(O)=C(CC2=CC=C(C=C2)C2=CC=CN=C2C)C(=O)N=C1C1=NN(CC)C=C1)C1=CC(F)=CC(F)=C1 Chemical compound CC[C@H](N1C(O)=C(CC2=CC=C(C=C2)C2=CC=CN=C2C)C(=O)N=C1C1=NN(CC)C=C1)C1=CC(F)=CC(F)=C1 LYZSSOLTQLAWLL-NDEPHWFRSA-N 0.000 claims 1
- FWOIKDQCQXZYAN-UHFFFAOYSA-N CCc1cccc(CC)c1-n1c(O)c(Cc2ccc(c(F)c2)-c2cccn(C)c2=O)c(=O)nc1-c1ccn(n1)C(C)C Chemical compound CCc1cccc(CC)c1-n1c(O)c(Cc2ccc(c(F)c2)-c2cccn(C)c2=O)c(=O)nc1-c1ccn(n1)C(C)C FWOIKDQCQXZYAN-UHFFFAOYSA-N 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 claims 1
- 208000006029 Cardiomegaly Diseases 0.000 claims 1
- 208000031229 Cardiomyopathies Diseases 0.000 claims 1
- 208000003037 Diastolic Heart Failure Diseases 0.000 claims 1
- DPIJKCHYBYVBAB-PMERELPUSA-N FC=1C=C(C#N)C=C(C=1)[C@H](C(C)C)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COC(C)C Chemical compound FC=1C=C(C#N)C=C(C=1)[C@H](C(C)C)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COC(C)C DPIJKCHYBYVBAB-PMERELPUSA-N 0.000 claims 1
- RFTQZZDJPLWTBG-LJAQVGFWSA-N FC=1C=C(C=C(C=1)F)[C@H](C(C)C)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COC(C)C Chemical compound FC=1C=C(C=C(C=1)F)[C@H](C(C)C)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COC(C)C RFTQZZDJPLWTBG-LJAQVGFWSA-N 0.000 claims 1
- SKZUDMNMNJKUOS-SANMLTNESA-N FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)=O)COC(C)C Chemical compound FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C(=NC=C1)F)C)=O)COC(C)C SKZUDMNMNJKUOS-SANMLTNESA-N 0.000 claims 1
- KNIFPMWEJBKNGF-MHZLTWQESA-N FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)=O)COC(C)C Chemical compound FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C1=C(C=NC=C1)C)=O)COC(C)C KNIFPMWEJBKNGF-MHZLTWQESA-N 0.000 claims 1
- PGHCGPKXOJQFGW-SANMLTNESA-N FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)=O)COC(C)C Chemical compound FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)=O)COC(C)C PGHCGPKXOJQFGW-SANMLTNESA-N 0.000 claims 1
- XUUWFRGQQNORJM-MHZLTWQESA-N FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COC(C)C Chemical compound FC=1C=C(C=C(C=1)F)[C@H](CC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COC(C)C XUUWFRGQQNORJM-MHZLTWQESA-N 0.000 claims 1
- ILUPLYFQSDKKFD-VWLOTQADSA-N FC=1C=C(C=C(C=1)F)[C@H](COC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)=O)COCC Chemical compound FC=1C=C(C=C(C=1)F)[C@H](COC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC(=CC=1)F)C)=O)COCC ILUPLYFQSDKKFD-VWLOTQADSA-N 0.000 claims 1
- HSWMHIYCSKSCGM-SANMLTNESA-N FC=1C=C(C=C(C=1)F)[C@H](COC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COCC Chemical compound FC=1C=C(C=C(C=1)F)[C@H](COC)N1C(=NC(C(=C1O)CC1=CC=C(C=C1)C=1C(=NC=CC=1)C)=O)COCC HSWMHIYCSKSCGM-SANMLTNESA-N 0.000 claims 1
- DMMONJNJUBALOL-VWLOTQADSA-N FC=1C=C(C=CC=1C=1C(N(C=CC=1)C)=O)CC=1C(N=C(N(C=1O)[C@@H](CC)C1=CC=CC=C1)C=1SC=C(N=1)C)=O Chemical compound FC=1C=C(C=CC=1C=1C(N(C=CC=1)C)=O)CC=1C(N=C(N(C=1O)[C@@H](CC)C1=CC=CC=C1)C=1SC=C(N=1)C)=O DMMONJNJUBALOL-VWLOTQADSA-N 0.000 claims 1
- 206010061216 Infarction Diseases 0.000 claims 1
- LBGVBXUDXKYZKJ-UHFFFAOYSA-N N-[4-[[1-(2,6-dimethoxyphenyl)-4-hydroxy-2-(3-methylbutyl)-6-oxopyrimidin-5-yl]methyl]phenyl]acetamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NC(=C(C1=O)CC1=CC=C(C=C1)NC(C)=O)O)CCC(C)C LBGVBXUDXKYZKJ-UHFFFAOYSA-N 0.000 claims 1
- YAQLAORCWVQJRT-UHFFFAOYSA-N N-[4-[[2-butyl-1-(2,6-dimethoxyphenyl)-4-hydroxy-6-oxopyrimidin-5-yl]methyl]phenyl]acetamide Chemical compound CCCCC1=NC(O)=C(CC2=CC=C(NC(C)=O)C=C2)C(=O)N1C1=C(OC)C=CC=C1OC YAQLAORCWVQJRT-UHFFFAOYSA-N 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000008253 Systolic Heart Failure Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 238000007675 cardiac surgery Methods 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000018578 heart valve disease Diseases 0.000 claims 1
- 230000007574 infarction Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 0 C*(Cc1c(*)ccc(CC(C(*(C(*)=N2)c3c(*)cccc3*)=O)=C2O)c1)=C Chemical compound C*(Cc1c(*)ccc(CC(C(*(C(*)=N2)c3c(*)cccc3*)=O)=C2O)c1)=C 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562263106P | 2015-12-04 | 2015-12-04 | |
| US62/263,106 | 2015-12-04 | ||
| PCT/US2016/064562 WO2017096130A1 (en) | 2015-12-04 | 2016-12-02 | Apelin receptor agonists and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018535999A JP2018535999A (ja) | 2018-12-06 |
| JP2018535999A5 true JP2018535999A5 (enExample) | 2020-01-16 |
| JP6817305B2 JP6817305B2 (ja) | 2021-01-20 |
Family
ID=57570463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018528638A Active JP6817305B2 (ja) | 2015-12-04 | 2016-12-02 | アペリン受容体アゴニストおよびその使用方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11390616B2 (enExample) |
| EP (1) | EP3383860B1 (enExample) |
| JP (1) | JP6817305B2 (enExample) |
| KR (1) | KR102678264B1 (enExample) |
| CN (1) | CN108473466B (enExample) |
| AR (1) | AR106948A1 (enExample) |
| AU (1) | AU2016365340B2 (enExample) |
| BR (1) | BR112018010720A8 (enExample) |
| CA (1) | CA3007280A1 (enExample) |
| CL (1) | CL2018001478A1 (enExample) |
| CO (1) | CO2018006662A2 (enExample) |
| EA (1) | EA037257B1 (enExample) |
| ES (1) | ES2858312T3 (enExample) |
| HK (1) | HK1255162A1 (enExample) |
| IL (1) | IL259660B (enExample) |
| MX (1) | MX381160B (enExample) |
| PE (1) | PE20181269A1 (enExample) |
| TW (1) | TW201722920A (enExample) |
| UY (1) | UY37005A (enExample) |
| WO (1) | WO2017096130A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
| TN2017000483A1 (en) | 2015-05-20 | 2019-04-12 | Amgen Inc | Triazole agonists of the apj receptor. |
| MY189453A (en) | 2015-06-03 | 2022-02-14 | Bristol Myers Squibb Co | 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders |
| CA3001974A1 (en) | 2015-10-14 | 2017-04-20 | Bristol-Myers Squibb Company | 2,4-dihydroxy-nicotinamides as apj agonists |
| WO2017096130A1 (en) | 2015-12-04 | 2017-06-08 | Bristol-Myers Squibb Company | Apelin receptor agonists and methods of use |
| TW201725203A (zh) | 2015-12-16 | 2017-07-16 | 必治妥美雅史谷比公司 | 作為ａｐｊ受體促效劑之雜芳基羥基嘧啶酮 |
| MA43761A (fr) | 2016-03-24 | 2021-05-05 | Bristol Myers Squibb Co | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides comme inhibiteurs de la apj |
| WO2017192485A1 (en) | 2016-05-03 | 2017-11-09 | Amgen Inc. | Heterocyclic triazole compounds as agonists of the apj receptor |
| CA3026512A1 (en) | 2016-06-13 | 2017-12-21 | Gilead Sciences, Inc. | Fxr (nr1h4) modulating compounds |
| CA2968836C (en) | 2016-06-13 | 2025-09-02 | Gilead Sciences Inc | Fxr (nr1h4) modulating compounds |
| US10508104B2 (en) | 2016-06-14 | 2019-12-17 | Bristol-Myers Squibb Company | 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists |
| KR102521955B1 (ko) | 2016-06-14 | 2023-04-13 | 브리스톨-마이어스 스큅 컴퍼니 | Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온 |
| EP3526198B1 (en) | 2016-10-14 | 2020-08-12 | Bristol-Myers Squibb Company | 3-sulfonyl-5-aminopyridine-2,4-diol apj agonists |
| MA46827A (fr) | 2016-11-16 | 2019-09-25 | Amgen Inc | Composés de triazole à substitution cycloalkyle en tant qu'agonistes du récepteur apj |
| WO2018093580A1 (en) | 2016-11-16 | 2018-05-24 | Amgen Inc. | Triazole pyridyl compounds as agonists of the apj receptor |
| US10906890B2 (en) | 2016-11-16 | 2021-02-02 | Amgen Inc. | Triazole phenyl compounds as agonists of the APJ receptor |
| WO2018097945A1 (en) | 2016-11-16 | 2018-05-31 | Amgen Inc. | Heteroaryl-substituted triazoles as apj receptor agonists |
| EP3541792B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole furan compounds as agonists of the apj receptor |
| US11191762B2 (en) | 2016-11-16 | 2021-12-07 | Amgen Inc. | Alkyl substituted triazole compounds as agonists of the APJ Receptor |
| EP4122464B1 (en) | 2017-03-28 | 2024-05-15 | Gilead Sciences, Inc. | Therapeutic combinations for treating liver diseases |
| WO2019089335A1 (en) | 2017-11-03 | 2019-05-09 | Amgen Inc. | Fused triazole agonists of the apj receptor |
| WO2019169193A1 (en) * | 2018-03-01 | 2019-09-06 | Annapurna Bio Inc. | Compounds and compositions for treating conditions associated with apj receptor activity |
| WO2019213006A1 (en) * | 2018-05-01 | 2019-11-07 | Amgen Inc. | Substituted pyrimidinones as agonists of the apj receptor |
| LT3911647T (lt) | 2019-01-15 | 2024-03-25 | Gilead Sciences, Inc. | Izoksazolo junginys kaip fxr agonistas ir jį apimančios farmacinės kompozicijos |
| CA3129949C (en) | 2019-02-19 | 2024-04-30 | Gilead Sciences, Inc. | Solid forms of fxr agonists |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2263639A (en) | 1992-01-28 | 1993-08-04 | Merck & Co Inc | Substituted pyrimidinones as neurotensin antagonists |
| DE4425616A1 (de) | 1994-07-20 | 1996-01-25 | Basf Ag | Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
| JPH08325248A (ja) | 1995-05-26 | 1996-12-10 | Chugoku Kayaku Kk | テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法 |
| BR9711098B1 (pt) | 1996-07-01 | 2011-10-04 | compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas. | |
| WO1999008501A2 (en) | 1998-04-23 | 1999-02-25 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| AU2001280590A1 (en) | 2000-07-18 | 2002-01-30 | Neurogen Corporation | 5-substituted 2-aryl-4-pyrimidinones |
| BR0307584A (pt) | 2002-02-22 | 2005-02-01 | Upjohn Co | Pirimidinonas e pirimidinationas substituìdas |
| WO2004094408A1 (en) | 2003-04-23 | 2004-11-04 | Pharmacia & Upjohn Company Llc | Substituted pyrimidinones and pyrimidinthiones as crf antagonists |
| WO2005026148A1 (en) | 2003-09-08 | 2005-03-24 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| JP2007518711A (ja) | 2003-12-19 | 2007-07-12 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂キネシン阻害剤 |
| US7973060B2 (en) | 2005-10-13 | 2011-07-05 | Crystalgenomics, Inc. | Fab I inhibitor and process for preparing same |
| KR20080080584A (ko) | 2005-11-30 | 2008-09-04 | 버텍스 파마슈티칼스 인코포레이티드 | ｃ-Ｍｅｔ의 억제제 및 이의 용도 |
| EP1903052A3 (en) * | 2006-07-28 | 2008-04-02 | Faust Pharmaceuticals SA | APJ receptor ligands and uses thereof |
| US9212130B2 (en) | 2010-08-10 | 2015-12-15 | Shionogi & Co., Ltd. | Heterocyclic derivative and pharmaceutical composition comprising the same |
| US20140005181A1 (en) * | 2012-06-21 | 2014-01-02 | Sanford-Burnham Medical Research Institute | Small molecule antagonists of the apelin receptor for the treatment of disease |
| EP2888256A4 (en) | 2012-08-24 | 2016-02-17 | Univ Texas | HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES |
| HUE031733T2 (en) * | 2012-09-21 | 2017-07-28 | Sanofi Sa | Benzimidazole carboxylic acid amide derivatives for the treatment of metabolic or cardiovascular diseases |
| MY189453A (en) | 2015-06-03 | 2022-02-14 | Bristol Myers Squibb Co | 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders |
| CA3001974A1 (en) | 2015-10-14 | 2017-04-20 | Bristol-Myers Squibb Company | 2,4-dihydroxy-nicotinamides as apj agonists |
| WO2017096130A1 (en) | 2015-12-04 | 2017-06-08 | Bristol-Myers Squibb Company | Apelin receptor agonists and methods of use |
| TW201725203A (zh) | 2015-12-16 | 2017-07-16 | 必治妥美雅史谷比公司 | 作為ａｐｊ受體促效劑之雜芳基羥基嘧啶酮 |
| MA43761A (fr) | 2016-03-24 | 2021-05-05 | Bristol Myers Squibb Co | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides comme inhibiteurs de la apj |
| KR102521955B1 (ko) | 2016-06-14 | 2023-04-13 | 브리스톨-마이어스 스큅 컴퍼니 | Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온 |
| US10508104B2 (en) | 2016-06-14 | 2019-12-17 | Bristol-Myers Squibb Company | 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists |
| EP3526198B1 (en) | 2016-10-14 | 2020-08-12 | Bristol-Myers Squibb Company | 3-sulfonyl-5-aminopyridine-2,4-diol apj agonists |
-
2016
- 2016-12-02 WO PCT/US2016/064562 patent/WO2017096130A1/en not_active Ceased
- 2016-12-02 PE PE2018001061A patent/PE20181269A1/es unknown
- 2016-12-02 AR ARP160103719A patent/AR106948A1/es unknown
- 2016-12-02 EA EA201891344A patent/EA037257B1/ru unknown
- 2016-12-02 UY UY2016037005A patent/UY37005A/es unknown
- 2016-12-02 US US15/779,194 patent/US11390616B2/en active Active
- 2016-12-02 ES ES16813199T patent/ES2858312T3/es active Active
- 2016-12-02 CA CA3007280A patent/CA3007280A1/en not_active Abandoned
- 2016-12-02 AU AU2016365340A patent/AU2016365340B2/en not_active Expired - Fee Related
- 2016-12-02 MX MX2018006217A patent/MX381160B/es unknown
- 2016-12-02 HK HK18114279.3A patent/HK1255162A1/zh unknown
- 2016-12-02 JP JP2018528638A patent/JP6817305B2/ja active Active
- 2016-12-02 BR BR112018010720A patent/BR112018010720A8/pt not_active IP Right Cessation
- 2016-12-02 EP EP16813199.3A patent/EP3383860B1/en active Active
- 2016-12-02 TW TW105140029A patent/TW201722920A/zh unknown
- 2016-12-02 KR KR1020187018588A patent/KR102678264B1/ko active Active
- 2016-12-02 CN CN201680070774.9A patent/CN108473466B/zh active Active
-
2018
- 2018-05-28 IL IL259660A patent/IL259660B/en active IP Right Grant
- 2018-06-01 CL CL2018001478A patent/CL2018001478A1/es unknown
- 2018-06-27 CO CONC2018/0006662A patent/CO2018006662A2/es unknown
-
2022
- 2022-06-09 US US17/836,596 patent/US12168655B2/en active Active